Mitochondrial Homeostasis in VSMCs as a Central Hub in Vascular Remodeling

Vascular remodeling is a common pathological hallmark of many cardiovascular diseases. Vascular smooth muscle cells (VSMCs) are the predominant cell type lining the tunica media and play a crucial role in maintaining aortic morphology, integrity, contraction and elasticity. Their abnormal proliferation, migration, apoptosis and other activities are tightly associated with a spectrum of structural and functional alterations in blood vessels. Emerging evidence suggests that mitochondria, the energy center of VSMCs, participate in vascular remodeling through multiple mechanisms. For example, peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α)-mediated mitochondrial biogenesis prevents VSMCs from proliferation and senescence. The imbalance between mitochondrial fusion and fission controls the abnormal proliferation, migration and phenotypic transformation of VSMCs. Guanosine triphosphate-hydrolyzing enzymes, including mitofusin 1 (MFN1), mitofusin 2 (MFN2), optic atrophy protein 1 (OPA1) and dynamin-related protein 1 (DRP1), are crucial for mitochondrial fusion and fission. In addition, abnormal mitophagy accelerates the senescence and apoptosis of VSMCs. PINK/Parkin and NIX/BINP3 pathways alleviate vascular remodeling by awakening mitophagy in VSMCs. Mitochondrial DNA (mtDNA) damage destroys the respiratory chain of VSMCs, resulting in excessive ROS production and decreased ATP levels, which are related to the proliferation, migration and apoptosis of VSMCs. Thus, maintaining mitochondrial homeostasis in VSMCs is a possible way to relieve pathologic vascular remodeling. This review aims to provide an overview of the role of mitochondria homeostasis in VSMCs during vascular remodeling and potential mitochondria-targeted therapies.

[1]  Haiyang Li,et al.  Astragaloside IV alleviates senescence of vascular smooth muscle cells through activating Parkin-mediated mitophagy , 2022, Human Cell.

[2]  J. Redondo,et al.  Rewiring Vascular Metabolism Prevents Sudden Death due to Aortic Ruptures—Brief Report , 2022, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Y. Pan,et al.  Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease. , 2022, Atherosclerosis.

[4]  J. Corpataux,et al.  Pharmacological prevention of intimal hyperplasia: A state-of-the-art review. , 2022, Pharmacology & therapeutics.

[5]  G. Zhu,et al.  Extracellular vesicles in vascular remodeling , 2022, Acta Pharmacologica Sinica.

[6]  G. Rabinovich,et al.  Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm , 2021, Science advances.

[7]  Junchao Duan,et al.  The mitochondria-targeted antioxidant MitoQ attenuated PM2.5-induced vascular fibrosis via regulating mitophagy , 2021, Redox biology.

[8]  E. Fisher,et al.  Fate and State of Vascular Smooth Muscle Cells in Atherosclerosis. , 2021, Circulation.

[9]  F. Jiang,et al.  The p53 pathway in vasculature revisited: a therapeutic target for pathological vascular remodeling? , 2021, Pharmacological research.

[10]  M. Lindsay,et al.  Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm , 2021, Circulation.

[11]  Hsiang-Yuan Yeh,et al.  Superoxide Dismutase 2 (SOD2) in Vascular Calcification: A Focus on Vascular Smooth Muscle Cells, Calcification Pathogenesis, and Therapeutic Strategies , 2021, Oxidative medicine and cellular longevity.

[12]  M. Bennett,et al.  Vascular smooth muscle cells in atherosclerosis:Time for a reassessment. , 2021, Cardiovascular research.

[13]  Ming-Wei Lin,et al.  Transplantation of viable mitochondria improves right ventricular performance and pulmonary artery remodeling in rats with pulmonary arterial hypertension. , 2020, The Journal of thoracic and cardiovascular surgery.

[14]  Toru Suzuki,et al.  Klf5 down-regulation induces vascular senescence through eIF5a depletion and mitochondrial fission , 2020, PLoS biology.

[15]  David R. Liu,et al.  A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing , 2020, Nature.

[16]  P. Little,et al.  Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function , 2020, Frontiers in Pharmacology.

[17]  S. Eguchi,et al.  Targeting Mitochondrial Fission as a Potential Therapeutic for Abdominal Aortic Aneurysm. , 2020, Cardiovascular research.

[18]  D. Catalucci,et al.  The role of mitochondrial dynamics in cardiovascular diseases , 2020, British journal of pharmacology.

[19]  Yuxuan Guo,et al.  Astaxanthin Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Oxidative Stress-Induced Mitochondrial Dysfunction , 2020, Oxidative medicine and cellular longevity.

[20]  Nai-Feng Liu,et al.  Lactate accelerates vascular calcification through NR4A1-regulated mitochondrial fission and BNIP3-related mitophagy , 2020, Apoptosis.

[21]  Han Liu,et al.  Hypermethylation of mitochondrial DNA in vascular smooth muscle cells impairs cell contractility , 2020, Cell Death & Disease.

[22]  Zhong Chen,et al.  Autophagy and Mitochondrial Encephalomyopathies. , 2020, Advances in experimental medicine and biology.

[23]  S. Zappavigna,et al.  Mitochondria as playmakers of apoptosis, autophagy and senescence. , 2020, Seminars in cell & developmental biology.

[24]  D. Chan.  Mitochondrial Dynamics and Its Involvement in Disease. , 2020, Annual review of pathology.

[25]  Sarah A. Smith,et al.  Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP , 2019, Cells.

[26]  Gerhard A Holzapfel,et al.  Biomechanics of Aortic Wall Failure with a Focus on Dissection and Aneurysm: A Review. , 2019, Acta biomaterialia.

[27]  M. Reilly,et al.  A protective smooth muscle cell transition in atherosclerosis , 2019, Nature Medicine.

[28]  F. Shen,et al.  Vascular smooth muscle cell senescence and age-related diseases: State of the art. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[29]  Y. Lecarpentier,et al.  Metabolic reprogramming in atherosclerosis: Opposed interplay between the canonical WNT/β-catenin pathway and PPARγ. , 2019, Journal of molecular and cellular cardiology.

[30]  A. Daiber,et al.  Resveratrol and Vascular Function , 2019, International journal of molecular sciences.

[31]  W. Martinet,et al.  Altered mitochondrial quality control in Atg7-deficient VSMCs promotes enhanced apoptosis and is linked to unstable atherosclerotic plaque phenotype , 2019, Cell Death & Disease.

[32]  Lanfang Li,et al.  PINK1/Parkin‐mediated mitophagy promotes apelin‐13‐induced vascular smooth muscle cell proliferation by AMPKα and exacerbates atherosclerotic lesions , 2018, Journal of cellular physiology.

[33]  T. Le,et al.  Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension. , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[34]  D. Altieri,et al.  Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension , 2018, American journal of respiratory and critical care medicine.

[35]  Merve Cakir,et al.  Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors , 2018, Nature Communications.

[36]  A. Avolio,et al.  Smooth muscle cell and arterial aging: basic and clinical aspects , 2018, Cardiovascular research.

[37]  M. Bennett,et al.  Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis , 2018, Cardiovascular research.

[38]  S. Allahverdian,et al.  Smooth muscle cell fate and plasticity in atherosclerosis , 2018, Cardiovascular research.

[39]  T. Minamino,et al.  Vascular Senescence in Cardiovascular and Metabolic Diseases , 2018, Front. Cardiovasc. Med..

[40]  Yaeni Kim,et al.  The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system. , 2018, Atherosclerosis.

[41]  R. Youle,et al.  Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance , 2018, Current Biology.

[42]  R. Touyz,et al.  Vascular smooth muscle contraction in hypertension , 2018, Cardiovascular research.

[43]  M. Bennett,et al.  Mitochondrial Respiration Is Reduced in Atherosclerosis, Promoting Necrotic Core Formation and Reducing Relative Fibrous Cap Thickness , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[44]  L. Tanaka,et al.  Vascular remodeling: A redox‐modulated mechanism of vessel caliber regulation , 2017, Free radical biology & medicine.

[45]  L. Galluzzi,et al.  Autophagy and Mitophagy in Cardiovascular Disease. , 2017, Circulation research.

[46]  A. Lawrie,et al.  Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension. , 2017, Trends in molecular medicine.

[47]  J. Elefteriades,et al.  Changing Pathology of the Thoracic Aorta From Acute to Chronic Dissection: Literature Review and Insights. , 2016, Journal of the American College of Cardiology.

[48]  S. Kelley,et al.  Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria. , 2016, Accounts of chemical research.

[49]  T. Länne,et al.  Altered PPARγ Coactivator-1 Alpha Expression in Abdominal Aortic Aneurysm: Possible Effects on Mitochondrial Biogenesis , 2016, Journal of Vascular Research.

[50]  Weihua Zhang,et al.  Exogenous H2S modulates mitochondrial fusion–fission to inhibit vascular smooth muscle cell proliferation in a hyperglycemic state , 2016, Cell & Bioscience.

[51]  M. Anand-Srivastava,et al.  Oxidative stress contributes to the enhanced expression of Gqα/PLCβ1 proteins and hypertrophy of VSMC from SHR: role of growth factor receptor transactivation. , 2016, American journal of physiology. Heart and circulatory physiology.

[52]  L. Scorrano,et al.  Mito-Morphosis: Mitochondrial Fusion, Fission, and Cristae Remodeling as Key Mediators of Cellular Function. , 2016, Annual review of physiology.

[53]  Sergio Lavandero,et al.  Mitochondrial dynamics, mitophagy and cardiovascular disease , 2016, The Journal of physiology.

[54]  R. Schnellmann,et al.  Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases. , 2016, Annual review of pharmacology and toxicology.

[55]  N. Cheshire,et al.  Aortic dissection , 2016, Nature Reviews Disease Primers.

[56]  Zhongjie Sun,et al.  Haplodeficiency of Klotho Gene Causes Arterial Stiffening via Upregulation of Scleraxis Expression and Induction of Autophagy , 2015, Hypertension.

[57]  Laura S. Shankman,et al.  KLF4 Dependent Phenotypic Modulation of SMCs Plays a Key Role in Atherosclerotic Plaque Pathogenesis , 2015, Nature Medicine.

[58]  Y. Yoon,et al.  Decreasing mitochondrial fission diminishes vascular smooth muscle cell migration and ameliorates intimal hyperplasia. , 2015, Cardiovascular research.

[59]  E. Schon,et al.  NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease , 2014, Cell metabolism.

[60]  M. Minczuk,et al.  Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations , 2014, EMBO molecular medicine.

[61]  J. Mercer.  Mitochondrial bioenergetics and therapeutic intervention in cardiovascular disease. , 2014, Pharmacology & therapeutics.

[62]  B. Hill,et al.  Mitochondrial fission induced by platelet-derived growth factor regulates vascular smooth muscle cell bioenergetics and cell proliferation☆ , 2013, Redox biology.

[63]  A. Burlingame,et al.  A Neo-Substrate that Amplifies Catalytic Activity of Parkinson’s-Disease-Related Kinase PINK1 , 2013, Cell.

[64]  M. Bennett,et al.  Mitochondrial DNA Damage Can Promote Atherosclerosis Independently of Reactive Oxygen Species Through Effects on Smooth Muscle Cells and Monocytes and Correlates With Higher-Risk Plaques in Humans , 2013, Circulation.

[65]  A. Bratić,et al.  The role of mitochondria in aging. , 2013, The Journal of clinical investigation.

[66]  R. Eils,et al.  Modulation of Serines 17 and 24 in the LC3-interacting Region of Bnip3 Determines Pro-survival Mitophagy versus Apoptosis* , 2012, The Journal of Biological Chemistry.

[67]  Lorenzo Galluzzi,et al.  Mitochondrial Control of Cellular Life, Stress, and Death , 2012, Circulation research.

[68]  S. Archer,et al.  Dynamin-Related Protein 1–Mediated Mitochondrial Mitotic Fission Permits Hyperproliferation of Vascular Smooth Muscle Cells and Offers a Novel Therapeutic Target in Pulmonary Hypertension , 2012, Circulation research.

[69]  G. Condorelli,et al.  Arterial remodeling and atherosclerosis: miRNAs involvement. , 2011, Vascular pharmacology.

[70]  H. Horita,et al.  SDF-1&agr; Induction in Mature Smooth Muscle Cells by Inactivation of PTEN Is a Critical Mediator of Exacerbated Injury-Induced Neointima Formation , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[71]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[72]  R. Virmani,et al.  Concept of vulnerable/unstable plaque. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[73]  Gene Kim,et al.  Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension: A Basis for Excessive Cell Proliferation and a New Therapeutic Target , 2010, Circulation.

[74]  E. K. Weir,et al.  Basic Science of Pulmonary Arterial Hypertension for Clinicians: New Concepts and Experimental Therapies , 2010, Circulation.

[75]  M. Louhelainen,et al.  Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes , 2010, Blood pressure.

[76]  R. Alexander,et al.  PGC-1α Serine 570 Phosphorylation and GCN5-mediated Acetylation by Angiotensin II Drive Catalase Down-regulation and Vascular Hypertrophy* , 2009, The Journal of Biological Chemistry.

[77]  M. Hermann,et al.  The cell-type specificity of mitochondrial dynamics. , 2009, The international journal of biochemistry & cell biology.

[78]  H. Tsutsui,et al.  Mitochondrial oxidative stress and dysfunction in myocardial remodelling. , 2008, Cardiovascular research.

[79]  K. Sunagawa,et al.  SIRT1, a Longevity Gene, Downregulates Angiotensin II Type 1 Receptor Expression in Vascular Smooth Muscle Cells , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[80]  M. Bennett,et al.  DNA damage and repair in atherosclerosis. , 2006, Cardiovascular research.

[81]  D. Chan.  Mitochondria: Dynamic Organelles in Disease, Aging, and Development , 2006, Cell.

[82]  A. M. James,et al.  Interactions of Mitochondria-targeted and Untargeted Ubiquinones with the Mitochondrial Respiratory Chain and Reactive Oxygen Species , 2005, Journal of Biological Chemistry.

[83]  N. Ashley,et al.  Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number. , 2004, Human molecular genetics.

[84]  J. Dyck,et al.  Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis , 2004, Circulation research.

[85]  Mario Fritsch Neves,et al.  Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial Dysfunction , 2004, Circulation.

[86]  Michael Hallek,et al.  Development of efficient viral vectors selective for vascular smooth muscle cells. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[87]  I. Komuro,et al.  Endothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction , 2002, Circulation.

[88]  B. Sobel,et al.  High Glucose Concentrations Induce Oxidative Damage to Mitochondrial DNA in Explanted Vascular Smooth Muscle Cells , 2001, Experimental biology and medicine.

[89]  D. Turnbull,et al.  Peptide nucleic acid delivery to human mitochondria , 1999, Gene Therapy.

[90]  B. Van Houten,et al.  Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[91]  M. Davies,et al.  Pathobiology of intimal hyperplasia , 1994, The British journal of surgery.

[92]  Mitsuyasu Kato,et al.  Competence Growth Factors Evoke the Phenotypic Transition of Arterial Smooth Muscle Cells a , 1990, Annals of the New York Academy of Sciences.

[93]  Denham Harman,et al.  The Biologic Clock: The Mitochondria? , 1972, Journal of the American Geriatrics Society.